Treatment Decisions of World Health Organization Grade II and III Ependymomas in Molecular Era
Journal of Korean Neurosurgical Society
;
: 312-318, 2018.
Article
in English
| WPRIM
| ID: wpr-765260
ABSTRACT
Surgery and radiotherapy are mainstays of treatment for ependymomas (EPNs). Recent molecular subgrouping could be superior to histopathological grading for predicting the prognosis of patients with EPNs. Gross total resection is an effective treatment approach regardless of its locations or pathologic grades. Adjuvant therapeutic strategies could be decided based on molecular subgrouping with risk-stratification. Information of histologic-molecular biology is now providing clues to therapeutic insights.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Radiotherapy
/
World Health Organization
/
Biology
/
Global Health
/
Ependymoma
/
Molecular Medicine
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Journal of Korean Neurosurgical Society
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS